Flavones have received considerable attention because of their antiproliferative properties and selective effects on cancer cells, making them good candidates for use in cancer therapy. In contrast to other flavones, little is known about the effects of the flavone core structure (2-phenyl-4H-1-benzopyran-4one) on cancer cells. Here, we report that flavone induces cell death in human hepatoma HepG2 cells. Furthermore, annexin-V + /PIand SubG1 populations of HepG2 cells increased after flavone treatment. Exposure of HepG2 to flavone did not result in either cytochrome c release into the cytosol or changes in the mitochondrial membrane potential. Treatment of HepG2 cells with flavone for 24 h reduced the accumulation of intracellular ROS, which correlated with upregulation of Gred, CuZnSOD and MnSOD mRNA levels. Taken together, our results provided useful insights into the mechanism of cell death caused by flavones, in order to evaluate their future application in hepatocarcinoma therapy.
Hepatocellular carcinoma (HCC) is one of the most common types of cancer, with a particularly high incidence in Asia [1, 2] . Nonsurgical treatments for HCC are either ineffective or may not improve overall survival [3] . It is, therefore, urgent to find new drugs with therapeutic potential for HCC treatment with minimal side effects.
Natural product-derived compounds have yielded encouraging results in the development of new anti-cancer agents. Flavonoids are polyphenolic compounds that are widely distributed in plants, and have several biological effects including antioxidant [4, 5] , antiinflammatory [6] , multidrug resistance (MDR) transporter inhibition [7, 8] , and antitumor activity [9] [10] [11] . Among the several flavonoid classes, flavones show a remarkable spectrum of biological activities [8, 10, 12] . Although several structure-activity relationship studies have been performed to assess the importance of flavone substituents, the effects of the flavone core structure remain unclear.
In a previous report, using an in vitro model of isolated rat liver mitochondria, we showed that the flavone core structure (2-phenyl-4H-1-benzopyran-4one) ( Figure 1A ) inhibits the mitochondrial respiratory chain and reduces the membrane potential [13] . In the cell culture model, flavone enhanced the expression of the p21/WAF1 gene, causing G1 phase arrest in A549 lung adenocarcinoma cells [14] . Previous results showed that flavone treatment (150 µmol/L) reduces cell proliferation in HT-29 cancer cells and that it was more efficient in causing apoptosis than the antitumor agent camptothecin [15, 16] . Although it has been shown that flavone modulates genes that regulate cell proliferation, the cell cycle, and apoptosis in breast cancer cells [17] , the mechanism by which the flavone selectively kills cancer cells is still unknown.
Here, we investigated the effects of the synthetic flavone core structure ( Figure 1A ) on HepG2 hepatocarcinoma cells and the mechanism by which it induces cell death. Specifically, the effects of flavone were investigated on cytochrome c release, alteration of mitochondrial membrane potential, the role of reactive oxygen species (ROS), and modulation of mRNA expression levels of the main cellular antioxidant enzymes.
The effects of flavone core structure on the growth of human HepG2 hepatoma cells were assessed by violet-crystal staining. HepG2 cells exposed to flavone doses lower than 25 µmol/L for up to 144 h did not induce cell death ( Figure 1B) . In contrast, exposing HepG2 cells to 50 and 100 µmol/L flavone caused a significant dose-and time-dependent decrease in cell viability. In summary, exposure of HepG2 cells to 100 µmol/L flavone for 24, 48, 96 and 144 h significantly inhibited cell growth by 13, 33, 62 and 71%, respectively (p< 0.05). Furthermore, the flavone-induced cytotoxic effect at 100 µmol/L was time-dependent up to 96 h, since no significant difference was observed between 96 and 144 h ( Figure  1B ). Interestingly, no cytotoxic effect was observed in the normal mouse liver cells treated with flavone core structure (10 -100 µmol/L) for either 24 or 48 h (data not shown), in accordance with previous reports [15, 17] .
To elucidate the mechanism of flavone-induced cell death in the hepatocarcinoma model, HepG2 cells were exposed to flavone core structure (100 µmol/L) for either 24 or 48 h, and then analyzed using an annexin-V and propidium iodide (PI) double-staining system, by flow cytometry. The annexin-V -/PIpopulation was regarded as normal healthy cells, while the annexin-V + /PIpopulation was taken to be cells in early apoptosis, due to phosphatidylserine externalization in the plasma membrane. We observed that flavone treatment of HepG2 cells for either 24 or 48 h induced a time-dependent increase in the percentage of annexin-V + /PIcells, reaching 12 and 16%, respectively ( Figure 1C ). We next examined the effect of flavone in the cell cycle, using PI staining. Treatment of HepG2 cells with flavone (100 µmol/L) led to an increase of DNA fragmentation, as assessed by the content of hypodiploid DNA (sub-G1 cell population) at 24 and 48 h ( Figure  1D ). These data are in agreement with the results for cell viability, suggesting that flavone is able to induce cell death in HepG2 cells by an apoptotic mechanism. Furthermore, the flavone treatment in HepG2 cells induced both DNA damage after 3 h of exposure and expression of p21 after 6 h of exposure (data not shown). These results suggest that flavone causes DNA breaks, which lead to a response to DNA damage, thus triggering DNA repair mechanisms.
To further exploit the signaling network responsible for flavoneinduced cell death and to take into consideration the possible involvement of the mitochondrial pathway, we evaluated the mitochondrial membrane potential (∆Ψ), using Rho-123, by means of flow cytometry. As shown in Figure 2A , exposure of HepG2 cells to flavone (100 µmol/L) for 24 or 48 h had no effect on ∆Ψ values, in contrast to our previous results using an in vitro model [13] . However, for HepG2 cells in the presence of p-trifluoromethoxy-carbonyl cyanide phenyl hydrazone (FCCP), an uncoupling agent used as a positive control, a significant decrease in Rho-123 fluorescence was evident (Figure 2A ). This demonstrated that the results using isolated mitochondria cannot be extrapolated to cell-line models probably due to differences in target access. However, in breast cancer cell-lines, other hydroxyflavones, such as apigenin and luteolin, caused a decrease in mitochondrial membrane potential, suggesting that this effect is linked to substituents present in the flavone core structure [18] .
We also measured the release of cytochrome c to the cytoplasm of HepG2 cells treated with flavone (100 µmol/L) for 24 h, and observed no significant differences relative to the control condition ( Figure 2B ). However, apigenin treatment of HepG2 cells (used as a positive control, as previously described in [12] ) led to a significant increase in cytochrome c release ( Figure 2B) . These results support the hypothesis that mitochondrial pathways are not involved in flavone-induced cell death in HepG2 cells. Therefore, the mechanism by which flavone core structure induces apoptosis in HepG2 cells is somewhat different from that proposed for other hydroxy-flavones, such as apigenin [12] . Based on the promising use of the apoptotic pathway as a therapeutic target against cancer [19] , further experiments are required to confirm the extrinsic apoptosis pathway induced by flavone.
To assess whether flavone treatment of HepG2 cells causes alteration of reactive oxygen species (ROS), intracellular ROS levels were measured by flow cytometry using the fluorescent probe 2′-7′-Dichlorodihydrofluorescein diacetate (DCF-DA). As shown in Figure 3A , exposure of HepG2 cells to flavone (100 µmol/L) for 24 h resulted in a reduction in intracellular ROS. In contrast, HepG2 cells treated with flavone for 1, 3, 6 or 48 h showed no change in intracellular ROS levels ( Figure 3A) .
To investigate why treatment with flavone for 24 h attenuated ROS generation and to identify the role of key antioxidant enzymes in this effect, we assessed the mRNA expression levels of glutathione reductase (Gred), catalase (CAT), glutathione peroxidase (GPx1), and superoxide dismutase (CuZnSOD and MnSOD) in HepG2 cells after 24 h exposure to flavone (100 µmol/L). The data for relative mRNA expression were normalized using the geNorm 3.4 software, with the corresponding housekeeping genes HPRT, tubulin and GAPDH. Analysis of mRNA expression levels of the antioxidant enzymes by qRT-PCR showed that Gred, CuZnSOD and MnSOD were upregulated (p<0.05) after exposure of HepG2 cells to flavone ( Figure 3B) . In contrast, flavone treatment resulted in significant downregulation of GPx1 (p<0.001). Surprisingly, mRNA catalase levels were unaffected ( Figure 3B ). This result strongly supports our hypothesis that flavone triggers a cell death mechanism by different pathways than those operating in hydroxy-flavones, since we have previously shown that catalase was an important target in apigenin-induced cell death [12] . Together, these results suggest that the cellular redox balance is maintained upon exposure to flavone.
Finally, we provided evidence that the mitochondria-independent pathway of apoptosis induced by flavone might be one of the mechanisms by which this polyphenol acts as a preventive antitumor drug against human hepatoma.
Experimental
Flavone solutions: Flavone was obtained from Sigma-Aldrich (St. Louis, MO, USA), dissolved in DMSO (100 mmol/L), and then further diluted in DMEM (Dulbecco's Modified Eagle Medium) high glucose medium (10-100 µmol/L). The flavone stock solution was stored at −20ºC.
HepG2 cell culture and cell viability assays:
The human hepatocarcinoma HepG2 cell line (from the American Type Culture Collection -ATCC) was maintained as previously described [12] . HepG2 cells were seeded at a density of 2.510 4 cells/well onto 24well culture plates. After overnight incubation, the cells were treated with different concentrations of flavone (10, 25, 50 or 100 µmol/L) for 24, 48, 96 or 144 h. Cell viability was evaluated through the crystal-violet staining assay, as described by [20] , and absorbance was determined at 550 nm using a TECAN Infinite ® 200 microplate reader. Control experiments were performed with DMEM high glucose containing 0.1% DMSO (v/v). The results were expressed as percentage of viable cells in comparison with the control (100%).
Determination of cytochrome c release:
Cells were seeded at a density of 110 6 cells per 60 mm plate. After overnight incubation, the cultures were treated with flavone (100 µmol/L) for 24 h and then washed with phosphate buffer saline (PBS). Cells were harvested and permeabilized with 10 µmol/L digitonin for 30 min at 4°C in a solution containing: 10 mg/mL Tris-HCl (pH 7.0), 3 mg/mL ethylene glycol tetraacetic acid (EGTA) and 50 μg/mL sucrose. The cells were then centrifuged at 10,000 g for 30 min. The supernatant was filtered through a 0.2 μm filter. The absorbance of cytochrome c released was evaluated in the clarified supernatants and recorded at 414 nm using the medium as a blank, in a spectrophotometer (Shimadzu UV-2450). The values were calculated according to ε = 100 mmol -1 .cm -1 of cytochrome c at 414 nm [21] .
Flow cytometry: Cell cycle analysis, determination of cell death by annexin V/propidium iodide (AV/PI) staining, mitochondrial membrane potential, and identification of ROS using oxidized 2'-7'-Dichlorodihydrofluorescein diacetate (DCF-DA) were analyzed by flow cytometry (FACSCalibur: Becton-Dickinson) and then by WinMDI 2.9 software. Human hepatoma HepG2 cells were seeded at a density of 510 5 cells onto 6-well plates. After overnight incubation, the cultures were treated with flavone for different time periods and the adhered cells were collected. The samples were washed once with PBS and harvested by a brief trypsinization, then centrifuged at 2,000 g for 3 min. The cell pellets were washed twice with PBS before loading with the specific dyes.
Determination of cell death by annexin V/propidium iodide (AV/PI):
HepG2 cells were treated with flavone (100 µmol/L) for either 24 or 48 h. The cell pellets were resuspended in 0.2 mL binding buffer [150 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , and 1.8 mM CaCl 2 in 10 mM HEPES (pH 7.4)], the cultures were centrifuged at 2,000 g for 2 min, and the pellets were resuspended in 100 µL of binding buffer with annexin V-FITC (1:1000) and incubated for 20 min in the dark. Finally, PI (10 µg/mL) dissolved in 300 µL of PBS was added at room temperature and subsequently analyzed by flow cytometry.
Cell cycle analysis:
The cell cycle was evaluated by the method of [22] . HepG2 cells were treated with flavone (100 µmol/L) for either 24 or 48 h. After the procedure described above, the cell pellets were loaded in 300 µL of propidium iodide (PI) solution (50 µg/mL PI and 0.1% Triton X-100 dissolved in PBS). Samples were examined after 10-20 min of staining at 4ºC.
Assessment of mitochondrial membrane potential:
The mitochondrial membrane potential was assessed by flow cytometry using Rhodamine 123 (Rh123). HepG2 cells were treated with flavone (100 µmol/L) for either 24 or 48 h. The cell pellets were resuspended in 0.3 mL of PBS containing 10 µM Rho123 and incubated in the dark at 37ºC for 20 min. Then, the cells were centrifuged at 2000 g for 2 min and resuspended in 300 µL of PBS. Finally, the Gmean of fluorescence intensity (Gmean) of Rho123, measured by flow cytometry, was used to determine the loss of mitochondrial membrane potential.
Identification of ROS using oxidized DCFDA:
Identification of ROS using oxidized 2′-7′-Dichlorodihydrofluorescein diacetate (DCFH-DA) was assessed by flow cytometry [23] . HepG2 cells were treated with flavone (100 µmol/L) for 1, 3, 6, 24 or 48 h. The cell pellets were resuspended in 0.3 mL of PBS containing 5 µM of DCFH-DA and incubated in the dark at 37ºC for 20 min. The cells were then centrifuged at 2,000 g for 2 min and resuspended in 300 µL of PBS. Finally, the Gmean of fluorescence intensity (Gmean) of DCF in the histograms measured by flow cytometry was used to determine the intracellular ROS accumulation.
